Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease

Int J Dermatol. 2023 Feb;62(2):246-249. doi: 10.1111/ijd.16376. Epub 2022 Aug 15.

Authors

Laura Atzori¹, Caterina Ferreli¹, Daniele Agosta¹, Marzia Mou², Pierpaolo Coni³, Joanna Izabela Lachowicz⁴, Luca Pilloni³

Affiliations

¹ Unit of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
² Private Practitioner, Jerzu, Italy.
³ Unit of Pathology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
⁴ Unit of Occupational Medicine, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

PMID: 35968714
DOI: 10.1111/ijd.16376

No abstract available

Publication types

Case Reports

MeSH terms

Hepatolenticular Degeneration* / complications
Hepatolenticular Degeneration* / drug therapy
Humans
Penicillamine / adverse effects
Scleroderma, Localized* / chemically induced
Scleroderma, Localized* / diagnosis
Scleroderma, Localized* / drug therapy
Scleroderma, Systemic* / chemically induced
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / drug therapy
Skin Diseases* / chemically induced
Skin Diseases* / complications
Skin Diseases* / drug therapy

Substances

Penicillamine

Supplementary concepts

Elastosis perforans serpiginosa